September 22, 9:00 – 9:30 AM EST
Drug Supply Chain Security Act (DSCSA) Overview: Are You Ready?
Senior Director of Community Engagement, Healthcare
66 Days to the final DSCSA deadline, November 27th of this year. In 2013, the United States Congress passed the Drug Supply Chain Security Act (DSCSA), to create a framework for governing the identification, management, and traceability of drug distribution within the United States. The objective of this law is to ensure patient safety by preventing illegitimate, counterfeit or recalled drug products from reaching patients. What is your organization’s role and are you ready for this final deadline—serialized unit-level traceability in an interoperable manner? Learn what the basic requirements are, what GS1 standards are being utilized by industry, and what resources are available to industry in meeting this new regulatory requirement.
Tracy Nasarenko, Senior Director of Community Engagement at GS1 US, is an accomplished leader with more than 20 years of experience in healthcare and pharmaceutical supply chain, finance, product management, marketing, and operations. In her current role, Ms. Nasarenko leads a collaborative pharmaceutical industry group focused on addressing supply chain challenges and meeting the requirement of the Drug Supply Chain Security Act (DSCSA). Using GS1 Standards, the most widely used supply chain standards in the world, Ms. Nasarenko guides the implementation of these standards to help the pharmaceutical industry deliver safe products to patients.
Prior to joining GS1 US, Ms. Nasarenko held several leadership positions with SPI Pharma Inc. Most recently, she served as a site general manager, overseeing end-to-end operations and the performance of the entire team, where she built a culture of engagement, innovation, and collaboration.
Ms. Nasarenko earned her bachelor’s degree from Villanova University and her Master of Business Administration from West Chester University.